Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1619-7089
    Keywords: Glucose transport ; Brain ; PET
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract A method was developed to measure simultaneously (1) the rate constants for glucose influex and glucose efflux, and (2) the Michaelis-Menten constant (K M ) and maximal velocity (V max) for glucose transport across the blood-brain barrier (BBB) in any selected brain area. Moreover, on the basis of a mathematical model, the local perfusion rate (LPR) and local unidirectional glucose transport rate (LUGTR) are calculated in terms of parameters of the time-activity curves registered over different brain regions; 11C-methyl-d-glucose (CMG) is used as an indicator. The transaxial distribution of activity in the organism is registered using dynamic positron-emission tomography (dPET). The method was used in 4 normal subjects and 50 patients with ischemic brain disease. In normals, the rate constant for CMG efflux was found to be 0.25±0.04 min-1 in the cortex and 0.12±0.02 min-1 in white matter. In the cortex, the K M was found to be 6.42 μmol/g and the V max was 2.46 μmol/g per minute. The LUGTR ranged from 0.43 to 0.6 μmol/g per minute in the cortex, and from 0.09 to 0.12 μmol/g per minute in white matter. The LPR was calculated to be 0.80–0.98 ml/g per minute for the cortex and 0.2–0.4 ml/g per minute for white matter. In patients with stroke, the ischemic defects appeared to be larger in CMG scans than in computed x-ray tomography (CT) scans. Prolonged reversible ischemic neurological deficit was associated with a significant fall in the LUGTR but no change in the LPR in the corresponding cerebral cortex. Normal LUGTR and significantly decreased LPR were registered in a patient with progressive occlusion of the middle cerebral artery. In a patient with transient ischemic attacks, a slightly reduced LPR and a disproportionally reduced LUGTR were observed before operation. After extra- and intrac-ranial bypass surgery, the LPR became normal, whereas the LUGTR increased but did not achieve normal values.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    European journal of nuclear medicine 7 (1982), S. 237-239 
    ISSN: 1619-7089
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Radiation from 99mTc was measured at typical locations in those areas of a nuclear medicine department where approximately 50 Ci 99mTc is used per year. In addition, measurements of shielded and unshielded syringes containing 99mTc-labelled radiopharmaceuticals were carried out. From these data radiation exposure of hands and of the whole body of personnel was calculated, taking into consideration the mean working times in the areas and the times of direct and indirect handling of 99mTc. They were compared with the mean values obtained by personnel dosimetry through quartz fibre pocket dosimeters and TLD finger ring dosimeters. The whole body radiation calculated from local measurements for technicians (163±15 mR/year) (mean±SE) and for physicians (260±15 mR/year) was very low judged by the maximum permissible dose of 5,000 mrem/year and correlated well with those of personnel dosimetry (165±15 R and 265±15 R/year respectively). Although local radiation was rather high during generator elution and while preparing radiopharmaceuticals (13±1.2 mR/h) the radiation exposure to the hands of the radiochemists measured by the TLD finger ring dosimeter was low (2.6±0.2 R/year). This was attained by consistently using long distance tools in order to avoid direct contact with 99mTc-containing vials and syringes. The most critical point of radiation exposure in our investigation were the finger tips during injection of 99mTc, when syringe shielding was not used (80–130 mR/injection of 10 mCi). Under our conditions this amounts to 330–560 R/year when a total of 40 Ci is injected by the same physician. This by far exceeds the maximum permissible dose of 60 rem/year. The dose can be reduced extensively to only 2–3 R/year when tungsten shielding of the syringe is consistently used.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...